Defibrillator market to reach $14.21 billion by 2021

Sarah Sipek | | Cardiovascular Business | Patient Care

The global defibrillator market is set to reach $14.21 billion by 2021—a 7.3 percent compound annual growth rate, according to current market research.

The growth is attributed to several factors, including the development of technologically advanced defibrillators, rapid growth in the aging population with high risk of target diseases, rising incidences of cardiovascular diseases across the globe, growing focus of public and private organizations and key market players toward public access defibrillation, and increasing number of training and awareness programs across the globe.

The current defibrillator market is divided into five major segments: pre-hospitals, public access markets, alternative care markets, home care and hospitals, clinics and cardiac centers. Currently, hospitals, clinics and cardiac centers account for the majority of defibrillator use. The public access markets are expected to grow at the fastest rate in the next five years.

Some key factors are restricting market growth, however. Despite the fact that sudden cardiac arrest is responsible for half of all heart disease deaths in the U.S.—approximately 325,000 each year according to the Cleveland Clinic—lack of awareness of the issue restricts defibrillator sales. In addition, unfavorable health care reforms have been a challenge for market retailers.

  

Sarah Sipek

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."